1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Systemic Scleroderma: new trials by email Literature Review of Systemic Scleroderma trials Research Report on Systemic Scleroderma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 24 | 2023-08-31 | 2023-09-28 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Dermatomyositis (1) · Lupus Erythematosus, Systemic (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Arthritis (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Dry Eye Syndromes (1) · Eye Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Lacrimal Apparatus Diseases (1) · Mouth Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Myositis (1) · Nervous System Diseases (1)
Chongqing Precision Biotech Co., Ltd (1)
China (1)
Liyun Zhang, M.D (1)